ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2258 participants.

Also called NCT01424722

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 2,258 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01424722
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01424722. Allocation not applicable; no masking; primary purpose diagnostic. Start 2011-08 (actual); primary completion 2017-06 (actual). Results posted on 2021-01-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Acronym
AnalyzeST
Intervention (Device)
Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01424722
Content hash
68c4668873f6378bad6ece0837608fc3757d5e954b84159f1fe9d36b4f0a5dda